Aviva’s MaxLinear MXL Stock Holding History

Aviva’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-42,343	Closed	-$1.49M	–	1004
2023 Q1	$1.49M	Buy	+42,343	New	+$1.53M	0.01%	736
2021 Q2	–	Sell	-37,125	Closed	-$1.26M	–	939
2021 Q1	$1.26M	Hold	37,125	–	–	0.01%	767
2020 Q4	$1.42M	Buy	+37,125	New	+$1.08M	0.01%	789

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aviva's MXL Position: Q2 2023 in Review

Aviva sold out of MaxLinear (MXL) in Q2 2023, closing a stake of 42,343 shares — an estimated $1.49M sold.

Aviva first reported a position in MXL in Q4 2020 and held it in 3 quarters. The position peaked at $1.49M in Q1 2023. 250 funds tracked by Wall St. Rank hold MXL as of Q2 2023.

Aviva reported no remaining MaxLinear position as of Q2 2023 after selling out during the quarter.
Aviva sold 42,343 MaxLinear shares in Q2 2023, an estimated $1.49M.
Aviva first reported a position in MaxLinear in Q4 2020 and held it in 3 quarters.
Aviva's MaxLinear position peaked at $1.49M in Q1 2023.
250 funds tracked by Wall St. Rank held MaxLinear as of Q2 2023.

Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.